AzTrials
AzTrials

Pulpectomy AgentsSLM2204NCT03731975

Endodontic Treatment Using CTZ Paste in Primary Teeth

A study testing CTZ Paste and GP Paste in people with Pulpectomy Agents, run by Faculty Sao Leopoldo Mandic Campinas at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate the efficacy of CTZ Paste in primary teeth, compared to endodontic treatment with Guedes-Pinto Paste. This is a multicenter, randomized, double-blind (patient), controlled and non-inferiority clinical study on 174 primary molars and 174 primary incisors of 3-6 years-old children… Read more about this study

Who is it for?
Ages 3 to 6 yearsHealthy volunteers can take part
Conditions the study is for
Pulpectomy Agents
What is being tested?
CTZ Paste and GP Paste
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
174 participants
Where
1 siteBrazil
Study dates
1 Jul 2017to 1 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 6 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • children aged from 3 to 6 years and 11 months;
  • children present at least one upper or lower molar or primary upper incisor with untreated carious lesion with pulp envelopment;
  • children assent to participate in the study through collaborative behavior;
  • children's parents/guardians consent to their participation by signing the Informed Consent Form (ICF).

Who cannot join

  • tooth with carious lesion involving three or more dental surfaces, making the restoration extremely difficult or impossible;
  • tooth with internal or external resorption in more than 1/3 of the root length;
  • tooth whose crypt of the successor permanent is affected;
  • tooth which have less than 2/3 of the root;
  • patients who present health problems with oral impairment.

Trial locations and contacts

1 site in 1 country.

Jose Imparato, Dr contact

+551130851046

jimparato@usp.br

Brazil1 site, 1 recruiting
  • Faculdade Sao Leopoldo Mandic

    Campinas, São Paulo, 13045-755

    Jose P Imparato, PhD, 55193518-3600, jimparato@usp.br

    Recruiting

Other trials in Brazil

About this study

Official title: Efficacy of Endodontic Treatment Using CTZ Paste in Primary Teeth: Randomized Clinical Trial

The aim of this study is to evaluate the efficacy of CTZ Paste in primary teeth, compared to endodontic treatment with Guedes-Pinto Paste. This is a multicenter, randomized, double-blind (patient), controlled and non-inferiority clinical study on 174 primary molars and 174 primary incisors of 3-6 years-old children with carious lesions with pulp involvement. The sample unit will be the tooth, which will be randomized into two groups. The teeth allocated to the experimental group will be treated with CTZ Paste, whereas the treatment of those teeth allocated to the control group will employ the Guedes-Pinto Paste. The procedures performed will be evaluated clinically and radiographically at 6 and 12 months. Secondary outcomes such as cost, discomfort, satisfaction and quality of life will also be evaluated.

Being tested
CTZ Paste, GP Paste
Keywords
Tooth, deciduous, Pulp Capping and Pulpectomy Agents, Pulpectomy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CTZ PasteProcedure or surgery

    Tooth allocated to this group will be treated with CTZ paste, according to the Cappielo's protocol (1964), updated by Moura et al. (2016).

  • GP PasteProcedure or surgery

    Tooth allocated to this group will be treated with Guedes-Pinto paste, according to the Guedes-Pinto's protocol (1981), updated by Mello-Moura et al. (2011).

Study groups in NCT03731975
Study groupRoleWhat they receive
CTZ PasteActive comparatorEndodontic treatment with CTZ paste.
Receives: Procedure: CTZ Paste
GP PasteExperimentalEndodontic treatment with Guedes-Pinto paste.
Receives: Procedure: GP Paste

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical and radiographical efficacy of the endodontic treatment

    The tooth will be evaluated according to the presence of mobility (yes or no) and regarding radiolucency area on initial and final radiography (measured and compared with the program ImageJ).

    Measured: 12 Months

Secondary outcomes (4)
  1. Cost-efficacy

    The costs of each treatment procedure will be calculated and compared with thresholds values for intervention cost-effectiveness by region, determined by World Health Organization (http://www.who.int/choice/costs/CER_levels/en/). These values will be combined with the evaluated efficacy of the treatments (according description of Outcome 1).

    Measured: Through study completion (12 months)

  2. Children's satisfaction with treatment

    The satisfaction of each treatment will be evaluated using the Wong-Baker Facial Scale (Wong \& Baker, 1988). The patient will be asked to choose the face that is more similar to how he/she felt during the treatment. The answer should be given solely by the child, which means no parental or professional interferences.

    Measured: Through study completion (12 months)

  3. Parents/Guardians' satisfaction with children's treatment

    The parents' satisfaction with each treatment will be evaluated using the Parent's Questionnaire about Teeth Appearance (Furtado et al., 2012).

    Measured: Through study completion (12 months)

  4. Impact of treatment on children's quality of life

    The oral health related quality of life will be measured using a validated questionnaire according to the children's age. The "Early Childhood Oral Health Impact Scale" (ECOHIS) (Tesch et al., 2008) will be applied with 4-5 years old patients. The "Child Perceptions Questionnaire" (CPQ) will be used for 6-9 years old patients (Martins et al., 2009). The same questionnaire will be applied immediately before the procedure and on 12 months follow-up. Only one type of questionnaire will be used with each child, according to its age.

    Measured: Baseline and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Nov 2018
  2. Study start1 Jul 2017
  3. Primary completion1 Dec 2018
  4. Study completion1 Dec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
174 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03731975
Sponsor's protocol ID
SLM4
Acronym
SLM2204
Status last verified
Dec 2018
First submitted
25 Oct 2018
Last updated
24 Dec 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Cappiello J. Tratamientos pulpares en incisivos primários. Rev Circ Od Ros 1964;52(4):133-45.

  • de Deus Moura Lde F, de Lima Mde D, Lima CC, Machado JI, de Moura MS, de Carvalho PV. Endodontic Treatment of Primary Molars with Antibiotic Paste: A Report of 38 Cases. J Clin Pediatr Dent. 2016;40(3):175-7. doi: 10.17796/1053-4628-40.3.175.

    PubMed 27472562
  • Furtado GE, Sousa ML, Barbosa TS, Wada RS, Martinez-Mier EA, Almeida ME. [Perceptions of dental fluorosis and evaluation of agreement between parents and children: validation of a questionnaire]. Cad Saude Publica. 2012 Aug;28(8):1493-505. doi: 10.1590/s0102-311x2012000800008. Portuguese.

    PubMed 22892969
  • Guedes-Pinto AC, De Paiva JG, Bozzola JR. [Endodontic treatment of deciduous teeth with pulp necrosis]. Rev Assoc Paul Cir Dent. 1981 May-Jun;35(3):240-4. No abstract available. Portuguese.

    PubMed 6943625
  • Mello-Moura AC, Fanaro J, Nicoletti MA, Mendes FM, Wanderley MT, Guedes-Pinto AC. Variability in the proportion of components of iodoform-based Guedes-Pinto paste mixed by dental students and pediatric dentists. Indian J Dent Res. 2011 Nov-Dec;22(6):781-5. doi: 10.4103/0970-9290.94668.

    PubMed 22484870
  • Monse B, Heinrich-Weltzien R, Benzian H, Holmgren C, van Palenstein Helderman W. PUFA--an index of clinical consequences of untreated dental caries. Community Dent Oral Epidemiol. 2010 Feb;38(1):77-82. doi: 10.1111/j.1600-0528.2009.00514.x. Epub 2009 Dec 7.

    PubMed 20002630
  • Wong DL, Baker CM. Smiling faces as anchor for pain intensity scales. Pain. 2001 Jan;89(2-3):295-300. doi: 10.1016/s0304-3959(00)00375-4. No abstract available.

    PubMed 11291631

Questions about this trial

What is this clinical trial studying?

A study testing CTZ Paste and GP Paste in people with Pulpectomy Agents, run by Faculty Sao Leopoldo Mandic Campinas at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jose Imparato, Dr (+551130851046, jimparato@usp.br), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical and radiographical efficacy of the endodontic treatment (time frame: 12 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03731975, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in